ÂÜÀòÂÒÂ×

Christopher Bolt is a Senior Scientist at Tessera Therapeutics, where responsibilities include managing and delegating experiments to investigate host-cell responses during transgenesis events. Prior experience includes serving as a Senior Lecturer at the University of Geneva and as a Scientist at EPFL, where Christopher Bolt led collaborative research programs focused on engineering DNA mutations in mice and fish to explore genetic causes of congenital anomalies. Christopher Bolt holds a PhD in Cellular and Developmental Biology from the University of Illinois Urbana-Champaign and a Bachelor of Science in Cell/Cellular and Molecular Biology from Bradley University.